With 3.05 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.49 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $17.0699 whereas the lowest price it dropped to was $14.91. The 52-week range on BBNX shows that it touched its highest point at $24.50 and its lowest point at $8.89 during that stretch. It currently has a 1-year price target of $23.67.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BBNX was up-trending over the past week, with a rise of 13.47%, but this was up by 15.11% over a month. A look at the trailing 12-month EPS for BBNX yields -1.69 with Next year EPS estimates of -1.84. For the next quarter, that number is -0.42. This implies an EPS growth rate of 75.78% for this year and 11.89% for next year.
Float and Shares Shorts:
At present, 43.47 million BBNX shares are outstanding with a float of 33.23 million shares on hand for trading. On 2025-07-15, short shares totaled 4.8 million, which was 1108.0 higher than short shares on 1749772800. In addition to Mr. Sean T. Saint PE as the firm’s President, CEO & Director, Mr. Stephen H. Feider serves as its CFO, Treasurer & Secretary.
Institutional Ownership:
Through their ownership of 0.98436 of BBNX’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, BBNX reported revenue of $17639000.0 and operating income of -$18642000.0. The EBITDA in the recently reported quarter was -$5588000.0 and diluted EPS was -$0.93.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With BBNX analysts setting a high price target of 30.0 and a low target of 17.0, the average target price over the next 12 months is 23.66667. Based on these targets, BBNX could surge 79.0% to reach the target high and rise by 1.43% to reach the target low. Reaching the average price target will result in a growth of 41.21% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.98953 being high and -$2.22513 being low. For BBNX, this leads to a yearly average estimate of -$2.13333. Based on analyst estimates, the high estimate for the next quarter is -$0.34 and the low estimate is -$0.49. The average estimate for the next quarter is thus -$0.4.
